Patents by Inventor Marie Makhlina

Marie Makhlina has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200276275
    Abstract: The invention relates to methods, uses, compositions and formulations including a melanocortin receptor-4 agonist and a glucagon-like peptide-1 receptor agonist for treatment of obesity, diabetes, metabolic syndrome and related indications, diseases or disorders.
    Type: Application
    Filed: May 19, 2020
    Publication date: September 3, 2020
    Inventors: Carl Spana, John H. Dodd, Marie Makhlina
  • Patent number: 10660939
    Abstract: The invention relates to methods, uses, compositions and formulations including a melanocortin receptor-4 agonist and a glucagon-like peptide-1 receptor agonist for treatment of obesity, diabetes, metabolic syndrome and related indications, diseases or disorders.
    Type: Grant
    Filed: October 3, 2017
    Date of Patent: May 26, 2020
    Assignee: Palatin Technologies, Inc.
    Inventors: Carl Spana, John H. Dodd, Marie Makhlina
  • Publication number: 20180153965
    Abstract: The invention relates to methods, uses, compositions and formulations including a melanocortin receptor-4 agonist and a glucagon-like peptide-1 receptor agonist for treatment of obesity, diabetes, metabolic syndrome and related indications, diseases or disorders.
    Type: Application
    Filed: October 3, 2017
    Publication date: June 7, 2018
    Inventors: Carl Spana, John H. Dodd, Marie Makhlina